Giuseppe Camporese Selected Research

Fluxum

2/2014

Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Camporese Research Topics

Disease

10	Venous Thromboembolism 01/2022 - 07/2008
9	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019 - 04/2002
8	Thrombosis (Thrombus) 09/2021 - 04/2002
7	COVID-19 01/2022 - 11/2020
6	Hemorrhage 01/2022 - 07/2008
3	Neoplasms (Cancer) 12/2021 - 12/2016
3	Thromboembolism 12/2021 - 02/2014
2	Pneumonia (Pneumonitis) 01/2022 - 01/2021
2	Atrial Fibrillation 01/2021 - 01/2018
1	Thoracic Outlet Syndrome (Syndrome, Thoracic Outlet) 01/2022
1	Obesity 01/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2021
1	Infections 01/2021
1	Stroke (Strokes) 01/2021
1	Thrombophilia 12/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Pulmonary Embolism 10/2018
1	Ischemic Stroke 01/2018
1	Carotid Artery Diseases 01/2018
1	Upper Extremity Deep Vein Thrombosis 12/2016
1	Shoulder Fractures 08/2014
1	Varicose Veins (Varicose Vein) 02/2014
1	Unstable Angina 01/2009
1	ST Elevation Myocardial Infarction 01/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2009
1	Atherosclerosis 05/2003
1	Thrombophlebitis 05/2002

Drug/Important Bio-Agent (IBA)

8	fibrin fragment D (D-dimer)IBA 01/2019 - 04/2002
7	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 05/2002
7	AnticoagulantsIBA 12/2021 - 05/2017
5	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2021 - 07/2008
3	Enoxaparin (Lovenox)FDA LinkGeneric 12/2021 - 10/2018
3	Vitamin K FDA Link 01/2021 - 05/2017
2	RivaroxabanIBA 01/2020 - 10/2018
2	parnaparinIBA 02/2014 - 01/2009
1	OligosaccharidesIBA 12/2021
1	GlycosaminoglycansIBA 12/2021
1	VaccinesIBA 09/2021
1	edoxabanIBA 01/2021
1	Viral RNAIBA 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 10/2018
1	Pharmaceutical PreparationsIBA 10/2018
1	N(4)-oleylcytosine arabinosideIBA 10/2018
1	FluxumIBA 02/2014
1	CalciumIBA 05/2003

Therapy/Procedure

4	Therapeutics 01/2021 - 05/2017
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2022
1	Contraindications 01/2021
1	Drug Tapering 01/2021
1	Critical Care (Surgical Intensive Care) 11/2020
1	Central Venous Catheters 12/2016
1	Operative Surgical Procedures 08/2014
1	Hemiarthroplasty 08/2014
1	Thrombolytic Therapy 09/2009
1	Compression Stockings 07/2008
1	Subcutaneous Injections 05/2002